Methodology for clinical trials in cancer patients with febrile neutropenia - Do we have a consensus?

被引：3

作者：

Feld, R ^{[1
]}

机构：

[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada

来源：

SUPPORTIVE CARE IN CANCER | 1998年 / 6卷 / 05期

关键词：

D O I：

10.1007/s005200050187

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：423 / 424

页数：2

共 16 条

[1]

[Anonymous], 1991, J Infect Dis, V163, P951

[2] A METHOD FOR ASSESSING THE QUALITY OF A RANDOMIZED CONTROL TRIAL [J].

CHALMERS, TC ;

SMITH, H ;

BLACKBURN, B ;

SILVERMAN, B ;

SCHROEDER, B ;

REITMAN, D ;

AMBROZ, A .

CONTROLLED CLINICAL TRIALS, 1981, 2 (01) :31-49

[3] PIPERACILLIN-TAZOBACTAM PLUS AMIKACIN VERSUS CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER [J].

COMETTA, A ;

ZINNER, S ;

DEBOCK, R ;

CALANDRA, T ;

GAYA, H ;

KLASTERSKY, J ;

LANGENAEKEN, J ;

PAESMANS, M ;

VISCOLI, C ;

GLAUSER, MP ;

GIBSON, B ;

SANZ, M ;

HANN, IM ;

FOLLATH, F ;

FATIO, R ;

FERSTER, A ;

VANHOOF, A ;

VANLANDUYT, H ;

ARENDT, V ;

HEMMER, R ;

PEETERMANS, M ;

PADMOS, A ;

SEITANIDES, B ;

HATZIYANNI, M ;

LOPEZ, A ;

PORCELLINI, A ;

GREK, V ;

CABALLERO, D ;

TOGNI, P ;

GALLAGHER, JG ;

GARAVENTA, A ;

MASSIMO, L ;

SUGAR, A ;

LEGRAND, JC ;

OPPENHEIM, B ;

PETRIKKOS, G ;

BEYTOUT, J ;

NIKOSKELAINEN, J ;

SHAPIRO, M ;

ESTAVOYER, JM ;

KERN, W .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :445-452

[4] CEFTAZIDIME COMPARED WITH PIPERACILLIN AND TOBRAMYCIN FOR THE EMPIRIC TREATMENT OF FEVER IN NEUTROPENIC PATIENTS WITH CANCER - A MULTICENTER RANDOMIZED TRIAL [J].

DEPAUW, BE ;

DERESINSKI, SC ;

FELD, R ;

LANEALLMAN, EF ;

DONNELLY, JP .

ANNALS OF INTERNAL MEDICINE, 1994, 120 (10) :834-844

[5]

ELLIOTT CR, 1988, CLIN INVEST MED, V11, P327

[6]

ELTING LS, 1981, SUPPORT CANC, V6, P457

[7] Criteria for response in patients in clinical trials of empiric antibiotic regimens for febrile neutropenia. Is there agreement? [J].

Feld, R .

SUPPORTIVE CARE IN CANCER, 1998, 6 (05) :444-448

[8] Empirical treatment of febrile neutropenia: Evolution of current therapeutic approaches [J].

Hathorn, JW ;

Lyke, K .

CLINICAL INFECTIOUS DISEASES, 1997, 24 :S256-S265

[9] EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF FEBRILE EPISODES IN NEUTROPENIC PATIENTS [J].

HUGHES, WT ;

PIZZO, PA ;

WADE, JC ;

ARMSTRONG, D ;

WEBB, CD ;

YOUNG, LS .

CLINICAL INFECTIOUS DISEASES, 1992, 15 :S206-S215

[10] 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever [J].

Hughes, WT ;

Armstrong, D ;

Bodey, GP ;

Brown, AE ;

Edwards, JE ;

Feld, R ;

Pizzo, P ;

Rolston, KVI ;

Shenep, JL ;

Young, LS .

CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :551-573

← 1 2 →